A Model for Predicting Response to PD-1 Inhibitors in NSCLC
Demographics (4)
- AGE - Subject age at enrollment (phv00435862.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00435874.v1.p1)
- SEX - Sex (phv00435860.v1.p1)
- SEX - Biological sex (phv00435856.v1.p1)
Disease Events (10)
- DISEASE - Cancer type (phv00435863.v1.p1)
- IS_TUMOR - Tumor status (phv00435872.v1.p1)
- OS_DAYS - Overall survival in days (phv00435865.v1.p1)
- OS_EVENT - Overall survival event (phv00435866.v1.p1)
- PFS_DAYS - Progression free survival in days (phv00435867.v1.p1)
- PFS_EVENT - Progression free survival event (phv00435868.v1.p1)
- TREATMENT - Treatment received (phv00435864.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00435878.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00435877.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00435879.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race/ethnicity (phv00435861.v1.p1)
Other (11)
- ANALYTE_TYPE - Analyte Type (phv00435871.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00435870.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00435855.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00435873.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00435875.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00435876.v1.p1)
- SAMPLE_ID - Sample ID (phv00435869.v1.p1)
- SAMPLE_ID - Sample ID (phv00435858.v1.p1)
- SUBJECT_ID - Subject ID (phv00435859.v1.p1)
- SUBJECT_ID - Subject ID (phv00435854.v1.p1)
- SUBJECT_ID - Subject ID (phv00435857.v1.p1)